AAI Calls on FTC to Investigate CVS Caremark’s Dominance

Nov 09 2010
Testimony and Interventions

In a letter to the directors of the Bureau of Competition and Bureau of Consumer Protection, the AAI called on the FTC to use its full Section 5 authority to  investigate whether CVS Caremark has been using its market dominance as a pharmacy benefits manager to suppress competition in retail pharmacy markets across the U.S.

Related News Stories:

Law360

Corporate Crime Reporter

DownloadSize
PDF icon CVS letter to FTC243.65 KB